Related references
Note: Only part of the references are listed.Bacteroidetes and Firmicutes levels in gut microbiota and effects of hosts TLR2/TLR4 gene expression levels in adult type 1 diabetes patients in Istanbul, Turkey
Mehmet Demirci et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2020)
The effect of Shengpuhuang-tang on retinal inflammation in streptozotocin-induced diabetic rats by NF-κB pathway
Wencan Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
San-Huang-Tang protects obesity/diabetes induced NAFLD by upregulating PGC-1α/PEPCK signaling in obese and galr1 knockout mice models
Penghua Fang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids
Ye Yao et al.
PHYTOMEDICINE (2020)
TGR5 Signaling in Hepatic Metabolic Health
Marlena M. Holter et al.
NUTRIENTS (2020)
Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids
Ye Yao et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis
Tsung-Ru Wu et al.
GUT (2019)
UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats
Yuhang Zhao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Akkermansia muciniphila is a promising probiotic
Ting Zhang et al.
MICROBIAL BIOTECHNOLOGY (2019)
The Chinese Herbal Formula Shenzhu Tiaopi Granule Results in Metabolic Improvement in Type 2 Diabetic Rats by Modulating the Gut Microbiota
Jindong Zhao et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Analysis of Health Benefits Conferred by Lactobacillus Species from Kefir
Conor Slattery et al.
NUTRIENTS (2019)
Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-Fu-Zhu-Yu decoction in coronary heart disease based on LC-Q-TOF/MS and GC-MS analysis
Min Yi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2019)
Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
Jia-Min Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids
Shi-Jun Yue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2019)
The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases
Alessia Pascale et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids
Kai Wang et al.
CELL REPORTS (2019)
In vitro study of antioxidant and antibacterial activities of Lactobacillus probiotic spp.
Z. Pourramezan et al.
FOLIA MICROBIOLOGICA (2018)
Dysbiosis Signatures of Gut Microbiota Along the Sequence from Healthy, Young Patients to Those with Overweight and Obesity
Renyuan Gao et al.
OBESITY (2018)
Flavonoid metabolism: the interaction of metabolites and gut microbiota
Kaeko Murota et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2018)
Intestinal Lactobacillus in health and disease, a driver or just along for the ride?
Dustin D. Heeney et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice
Eleni Beli et al.
DIABETES (2018)
Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-JiaoTai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis
Wenbo Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Liping Zhao et al.
SCIENCE (2018)
Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae
Rebekah M. Martin et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
FXR modulators for enterohepatic and metabolic diseases
Hong Wang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota
Xiaoyan Wei et al.
SCIENTIFIC REPORTS (2018)
Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes
Elizabeth L. Johnson et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
iTRAQ-Based Quantitative Proteomics Analysis of the Protective Effect of Yinchenwuling Powder on Hyperlipidemic Rats
Zheyu Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Dahuang Zexie Decoction Protects against High-Fat Diet-Induced NAFLD by Modulating Gut Microbiota-Mediated Toll-Like Receptor 4 Signaling Activation and Loss of Intestinal Barrier
Jing Fang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
Yanyun Gu et al.
NATURE COMMUNICATIONS (2017)
Mechanisms and therapeutic effectiveness of lactobacilli
Alessandro Di Cerbo et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Annika Wahlstrom et al.
CELL METABOLISM (2016)
Proteomic analysis allows for identifying targets of Yinchenwuling Powder in hyperlipidemic rats
Ruomeng Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
Alexandra Zhernakova et al.
SCIENCE (2016)
Mining metagenomic whole genome sequences revealed subdominant but constant Lactobacillus population in the human gut microbiota
Maddalena Rossi et al.
ENVIRONMENTAL MICROBIOLOGY REPORTS (2016)
The incretin hormone GLP-1 and mechanisms underlying its secretion
Lili Tian et al.
JOURNAL OF DIABETES (2016)
Hypoglycemic and hypolipidemic properties of polysaccharides from Enterobacter cloacae Z0206 in KKAy mice
Ming Huang et al.
CARBOHYDRATE POLYMERS (2015)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
Stefano Fiorucci et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Bile acid nuclear receptor FXR and digestive system diseases
Lili Ding et al.
ACTA PHARMACEUTICA SINICA B (2015)
Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula
Jia Xu et al.
ISME JOURNAL (2015)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Nadja Larsen et al.
PLOS ONE (2010)
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Charles Thomas et al.
CELL METABOLISM (2009)
Traditional Chinese Medicine in Treatment of Metabolic Syndrome
Jun Yin et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Share Paper
